These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
174 related articles for article (PubMed ID: 12193582)
1. Estrogen receptor-related receptor alpha impinges on the estrogen axis in bone: potential function in osteoporosis. Bonnelye E; Kung V; Laplace C; Galson DL; Aubin JE Endocrinology; 2002 Sep; 143(9):3658-70. PubMed ID: 12193582 [TBL] [Abstract][Full Text] [Related]
2. The orphan nuclear estrogen receptor-related receptor alpha (ERRalpha) is expressed throughout osteoblast differentiation and regulates bone formation in vitro. Bonnelye E; Merdad L; Kung V; Aubin JE J Cell Biol; 2001 May; 153(5):971-84. PubMed ID: 11381083 [TBL] [Abstract][Full Text] [Related]
3. Exposure of KS483 cells to estrogen enhances osteogenesis and inhibits adipogenesis. Dang ZC; van Bezooijen RL; Karperien M; Papapoulos SE; Löwik CW J Bone Miner Res; 2002 Mar; 17(3):394-405. PubMed ID: 11878304 [TBL] [Abstract][Full Text] [Related]
4. Estrogen receptor-related receptor alpha: a mediator of estrogen response in bone. Bonnelye E; Aubin JE J Clin Endocrinol Metab; 2005 May; 90(5):3115-21. PubMed ID: 15713703 [TBL] [Abstract][Full Text] [Related]
5. The beneficial effect of icaritin on osteoporotic bone is dependent on the treatment initiation timing in adult ovariectomized rats. Peng S; Zhang G; Zhang BT; Guo B; He Y; Bakker AJ; Pan X; Zhen W; Hung L; Qin L; Leung WN Bone; 2013 Jul; 55(1):230-40. PubMed ID: 23486180 [TBL] [Abstract][Full Text] [Related]
6. Absence of estrogen receptor-related-alpha increases osteoblastic differentiation and cancellous bone mineral density. Delhon I; Gutzwiller S; Morvan F; Rangwala S; Wyder L; Evans G; Studer A; Kneissel M; Fournier B Endocrinology; 2009 Oct; 150(10):4463-72. PubMed ID: 19608650 [TBL] [Abstract][Full Text] [Related]
7. Estrogen modulates estrogen receptor alpha and beta expression, osteogenic activity, and apoptosis in mesenchymal stem cells (MSCs) of osteoporotic mice. Zhou S; Zilberman Y; Wassermann K; Bain SD; Sadovsky Y; Gazit D J Cell Biochem Suppl; 2001; Suppl 36():144-55. PubMed ID: 11455579 [TBL] [Abstract][Full Text] [Related]
8. Estrogen receptor-alpha is developmentally regulated during osteoblast differentiation and contributes to selective responsiveness of gene expression. Bodine PV; Henderson RA; Green J; Aronow M; Owen T; Stein GS; Lian JB; Komm BS Endocrinology; 1998 Apr; 139(4):2048-57. PubMed ID: 9528993 [TBL] [Abstract][Full Text] [Related]
9. Estrogen receptor-related receptor alpha (ERRalpha) regulates osteopontin expression through a non-canonical ERRalpha response element in a cell context-dependent manner. Zirngibl RA; Chan JS; Aubin JE J Mol Endocrinol; 2008 Feb; 40(2):61-73. PubMed ID: 18234909 [TBL] [Abstract][Full Text] [Related]
10. Differential expression of estrogen receptor-related receptor alpha and estrogen receptors alpha and beta in osteoblasts in vivo and in vitro. Bonnelye E; Aubin JE J Bone Miner Res; 2002 Aug; 17(8):1392-400. PubMed ID: 12162493 [TBL] [Abstract][Full Text] [Related]
11. Expression profiles of receptor activator of nuclear factor kappaB ligand, receptor activator of nuclear factor kappaB, and osteoprotegerin messenger RNA in aged and ovariectomized rat bones. Ikeda T; Utsuyama M; Hirokawa K J Bone Miner Res; 2001 Aug; 16(8):1416-25. PubMed ID: 11499864 [TBL] [Abstract][Full Text] [Related]
12. Cellular and molecular effects of growth hormone and estrogen on human bone cells. Kassem M APMIS Suppl; 1997; 71():1-30. PubMed ID: 9357492 [TBL] [Abstract][Full Text] [Related]
13. Activation of the osteopontin promoter by the orphan nuclear receptor estrogen receptor related alpha. Vanacker JM; Delmarre C; Guo X; Laudet V Cell Growth Differ; 1998 Dec; 9(12):1007-14. PubMed ID: 9869301 [TBL] [Abstract][Full Text] [Related]
14. Transient Effect of 17β-estradiol on Osteoporosis in Ovariectomized Rats Accompanied with Unilateral Disuse in the Early Phase. Sun X; Liang J; Wang C; Cao S; Hu Y; Xu X Int J Med Sci; 2015; 12(5):423-31. PubMed ID: 26078702 [TBL] [Abstract][Full Text] [Related]
15. The cross-talk between osteoclasts and osteoblasts in response to strontium treatment: involvement of osteoprotegerin. Peng S; Liu XS; Huang S; Li Z; Pan H; Zhen W; Luk KD; Guo XE; Lu WW Bone; 2011 Dec; 49(6):1290-8. PubMed ID: 21925296 [TBL] [Abstract][Full Text] [Related]
16. Parathyroid hormone stimulates TRANCE and inhibits osteoprotegerin messenger ribonucleic acid expression in murine bone marrow cultures: correlation with osteoclast-like cell formation. Lee SK; Lorenzo JA Endocrinology; 1999 Aug; 140(8):3552-61. PubMed ID: 10433211 [TBL] [Abstract][Full Text] [Related]
17. Expression of estrogen receptor beta in rat bone. Onoe Y; Miyaura C; Ohta H; Nozawa S; Suda T Endocrinology; 1997 Oct; 138(10):4509-12. PubMed ID: 9322974 [TBL] [Abstract][Full Text] [Related]
18. Isopropanolic extract of black cohosh stimulates osteoprotegerin production by human osteoblasts. Viereck V; Gründker C; Friess SC; Frosch KH; Raddatz D; Schoppet M; Nisslein T; Emons G; Hofbauer LC J Bone Miner Res; 2005 Nov; 20(11):2036-43. PubMed ID: 16234977 [TBL] [Abstract][Full Text] [Related]
19. Estrogen-related receptor α is involved in the osteogenic differentiation of mesenchymal stem cells isolated from human periodontal ligaments. Cai C; Yuan GJ; Huang Y; Yang N; Chen X; Wen L; Wang X; Zhang L; Ding Y Int J Mol Med; 2013 May; 31(5):1195-201. PubMed ID: 23525223 [TBL] [Abstract][Full Text] [Related]
20. Nitric oxide donor increases osteoprotegerin production and osteoclastogenesis inhibitory activity in bone marrow stromal cells from ovariectomized rats. Wang FS; Wang CJ; Chen YJ; Huang YT; Huang HC; Chang PR; Sun YC; Yang KD Endocrinology; 2004 May; 145(5):2148-56. PubMed ID: 14962990 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]